Literature DB >> 25120228

Perceptions of mailed HPV self-testing among women at higher risk for cervical cancer.

Kayoll V Galbraith1, Melissa B Gilkey, Jennifer S Smith, Alice R Richman, Lynn Barclay, Noel T Brewer.   

Abstract

Whether human papillomavirus (HPV) self-testing can expand access to cervical cancer screening will depend on making the test accessible and acceptable to higher-risk women. To evaluate a novel delivery mode, we mailed HPV self-test kits to low-income, under-screened women and assessed their perceptions of self-testing and cervical cancer prevention. We conducted a telephone survey of 199 women in North Carolina. Eligibility criteria included not having had a Pap test in 4 years and reporting 1 or more indicators of economic hardship, such as being uninsured. Over half (55 %) of women in the diverse sample were non-Hispanic black, and almost three-quarters (74 %) reported annual household incomes of $20,000 or less. Trust in HPV self-testing was moderate to high, with almost all women (98 %) agreeing the mailed test was safe. A few women (6 %) preferred HPV self-testing to Pap testing for protecting health, but most (75 %) had no preference. Trust in or preference for mailed self-testing did not vary by race or income. However, compared to white women, black women had lower HPV-related knowledge (OR 0.46, 95 % CI 0.23-0.92) and perceived lower cervical cancer risk in the absence of screening (OR 0.44, 95 % CI 0.22-0.86). We found similar patterns of disparities for women with very low (<$10,000) versus relatively higher incomes. Our findings suggest that, across racial and economic subgroups, under-screened women generally trust HPV self-tests delivered by mail. To succeed, programs for HPV self-testing must overcome disparities in knowledge and perceptions related to cervical cancer screening.

Entities:  

Mesh:

Year:  2014        PMID: 25120228      PMCID: PMC4316669          DOI: 10.1007/s10900-014-9931-x

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  11 in total

Review 1.  Cancers with increasing incidence trends in the United States: 1999 through 2008.

Authors:  Edgar P Simard; Elizabeth M Ward; Rebecca Siegel; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

2.  Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.

Authors:  Akhila Balasubramanian; Shalini L Kulasingam; Atar Baer; James P Hughes; Evan R Myers; Constance Mao; Nancy B Kiviat; Laura A Koutsky
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

3.  Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.

Authors:  Eduardo Lazcano-Ponce; Attila Tibor Lorincz; Aurelio Cruz-Valdez; Jorge Salmerón; Patricia Uribe; Eduardo Velasco-Mondragón; Pilar Hernandez Nevarez; Rodrigo Diaz Acosta; Mauricio Hernández-Avila
Journal:  Lancet       Date:  2011-11-01       Impact factor: 79.321

4.  Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.

Authors:  Isabel C Scarinci; Allison G Litton; Isabel C Garcés-Palacio; Edward E Partridge; Philip E Castle
Journal:  Womens Health Issues       Date:  2013-02-12

Review 5.  Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis.

Authors:  Patrick Petignat; Daniel L Faltin; Ilan Bruchim; Martin R Tramèr; Eduardo L Franco; François Coutlée
Journal:  Gynecol Oncol       Date:  2007-02-28       Impact factor: 5.482

6.  Acceptability of self-collection of specimens for HPV DNA testing in an urban population.

Authors:  R Anhang; J A Nelson; R Telerant; M A Chiasson; Thomas C Wright
Journal:  J Womens Health (Larchmt)       Date:  2005-10       Impact factor: 2.681

7.  Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000.

Authors:  Gopal K Singh; Barry A Miller; Benjamin F Hankey; Brenda K Edwards
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  Cervical cancer screening preferences among African American women in the Mississippi Delta.

Authors:  Allison G Litton; Philip E Castle; Edward E Partridge; Isabel C Scarinci
Journal:  J Health Care Poor Underserved       Date:  2013-02

9.  Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women.

Authors:  Israel De Alba; Hoda Anton-Culver; F Allan Hubbell; Argyrios Ziogas; James R Hess; America Bracho; Caleb Arias; Alberto Manetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

10.  Cancer mortality in the United States by education level and race.

Authors:  Jessica D Albano; Elizabeth Ward; Ahmedin Jemal; Robert Anderson; Vilma E Cokkinides; Taylor Murray; Jane Henley; Jonathan Liff; Michael J Thun
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506

View more
  12 in total

Review 1.  Acceptability, Feasibility and Uptake of HPV Self-Sampling Among Immigrant Minority Women: a Focused Literature Review.

Authors:  Sarah Marshall; Mandana Vahabi; Aisha Lofters
Journal:  J Immigr Minor Health       Date:  2019-12

2.  Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff.

Authors:  Brynne E Presser; Mira L Katz; Abigail B Shoben; Deborah Moore; Mack T Ruffin; Electra D Paskett; Paul L Reiter
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

Review 3.  Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.

Authors:  Tina R Madzima; Mandana Vahabi; Aisha Lofters
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

4.  Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.

Authors:  Mira L Katz; Barret J Zimmermann; Deborah Moore; Electra D Paskett; Paul L Reiter
Journal:  Women Health       Date:  2016-10-04

Review 5.  Variation in Cervical Cancer Screening Preferences among Medically Underserved Individuals in the United States: A Systematic Review.

Authors:  Caitlin B Biddell; Meghan C O'Leary; Stephanie B Wheeler; Lisa P Spees
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-26       Impact factor: 4.254

6.  Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge.

Authors:  Sonia Andersson; Karen Belkić; Selin Safer Demirbüker; Miriam Mints; Ellinor Östensson
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

Review 7.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

8.  Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?

Authors:  Sonia Andersson; Karen Belkić; Miriam Mints; Ellinor Östensson
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

9.  Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia.

Authors:  Ellinor Östensson; Karen Belkić; Torbjörn Ramqvist; Miriam Mints; Sonia Andersson
Journal:  Oncol Lett       Date:  2021-01-31       Impact factor: 2.967

10.  A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.

Authors:  Erika Biederman; Victoria Champion; Gregory Zimet
Journal:  BMC Womens Health       Date:  2020-03-19       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.